| Sep 23 |
Forecasting The Future: 20 Analyst Projections For Biogen
|
| Sep 20 |
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ™
|
| Sep 18 |
Biogen Inc. (BIIB) Cantor Fitzgerald Global Healthcare Conference (Transcript)
|
| Sep 16 |
Hope remains that Roche’s prasinezumab can overcome recent string of failures in Parkinson’s disease
|
| Sep 13 |
Subcutaneous Tecentriq gets FDA OK; Gilead shot succeeds in second HIV trial
|
| Sep 12 |
Healthcare Stocks Have Popped. Consider These 2 That Haven’t.
|
| Sep 12 |
Biogen Board Appoints Two New Independent Directors
|
| Sep 10 |
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
|
| Sep 10 |
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
|
| Sep 6 |
Biogen’s higher Spinraza dose shows better efficacy in Phase II/III trial
|
